ABUS vs GOOGL: Which Stock is Better?
Side-by-side comparison of Arbutus Biopharma Corp and Alphabet Inc in 2026
ABUS
Arbutus Biopharma Corp
$4.21
GOOGL
Alphabet Inc
$322.00
Key Metrics Comparison
| Metric | ABUS | GOOGL | Winner |
|---|---|---|---|
| Market Cap | $780.84M | $3.89T | GOOGL |
| P/E Ratio | N/A | 31.76 | GOOGL |
| EPS (TTM) | $N/A | $10.14 | GOOGL |
| Revenue Growth | -0.6% | 0.2% | GOOGL |
| Gross Margin | -98.9% | 59.2% | GOOGL |
Analyze ABUS
Full quant analysis
Analyze GOOGL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ABUS or GOOGL a better investment?
Comparing ABUS and GOOGL: Arbutus Biopharma Corp has a market cap of $780.84M while Alphabet Inc has $3.89T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ABUS and GOOGL?
ABUS (Arbutus Biopharma Corp) and GOOGL (Alphabet Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ABUS or GOOGL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ABUS or GOOGL?
GOOGL has higher revenue growth at 0.2% vs -0.6% for ABUS.
Which company is more profitable: ABUS or GOOGL?
Alphabet Inc (GOOGL) has higher gross margins at 59.2% compared to -98.9% for ABUS.
Which is the larger company: ABUS or GOOGL?
Alphabet Inc (GOOGL) is larger with a market cap of $3.89T compared to $780.84M for ABUS.
Should I buy ABUS or GOOGL in 2026?
Both ABUS and GOOGL have investment merit. ABUS trades at $4.21 while GOOGL trades at $322.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ABUS and GOOGL stock?
Key differences: Market Cap ($780.84M vs $3.89T), P/E Ratio (N/A vs 31.8x), Revenue Growth (-0.6% vs 0.2%), Gross Margin (-98.9% vs 59.2%).